Abstract
Treatment of autoimmune disease with bone marrow transplantation (BMT) is under investigation. A few reports of patients undergoing allogeneic BMT for malignant conditions observed the resolution of psoriasis after BMT, with minimal late morbidity. We describe a patient with chronic myelogenous leukemia (CML) whose psoriasis resolved completely after allogeneic BMT. However, the patient's course was complicated by extensive chronic graft-versus-host disease (GVHD), recurrent serious infections, poor performance status and quality of life, and severe disability. The patient died 887 days post transplant due to infectious complications. The potential benefits and risks of treatment of autoimmune diseases with allogeneic BMT are discussed. Bone Marrow Transplantation (2000) 26, 1239–1241.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stern RS . Psoriasis Lancet 1997 350: 349–353
Robert C, Kupper TS . Inflammatory skin diseases, T cells, and immune surveillance New Engl J Med 1999 341: 1817–1828
Sullivan KM, Nelson JL, Arnason B et al. Evolving role of hematopoietic stem cell transplantation in autoimmune disease. In: McArthur JR, Schechter GP, Bajus JL (eds) American Society of Hematology Educational Book Washington DC 1998 pp 198–214
Eedy DJ, Burrows D, Bridges JM, Jones FGC . Clearance of severe psoriasis after allogeneic bone marrow transplantation BMJ 1990 300: 908–909
Jowitt SN, Liu Yin JA . Psoriasis and bone marrow transplantation BMJ 1990 300: 1398–1399
Liu Yin JA, Jowitt SN . Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia Bone Marrow Transplant 1992 9: 31–33
Kishimoto Y, Yamamoto Y, Ito T et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 1041–1043
Snowden JA, Kearney P, Kearney A et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation Arthritis Rheumatism 1998 41: 453–459
Tyndall A, Fassas A, Passweg J et al. Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality Bone Marrow Transplant 1999 24: 729–734
Adkins D, Pence H, Brown R et al. Low-dose (550 cGy) total body irradiation (TBI) given in a single dose results in consistent, durable engraftment of related donor (RD) peripheral blood stem cells (PBSC), with a low 100 day treatment-related mortality (TRM) of 9% Blood 1999 94: 711a (Abstr. 3140)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adkins, D., Abidi, M., Brown, R. et al. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. Bone Marrow Transplant 26, 1239–1241 (2000). https://doi.org/10.1038/sj.bmt.1702703
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702703
- Springer Nature Limited
Keywords
This article is cited by
-
Psoriasis in the transplant population
Archives of Dermatological Research (2022)
-
Alopecia areata after HLA-identical BMT from an affected, sibling donor
Bone Marrow Transplantation (2014)
-
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2003)
-
Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases
Bone Marrow Transplantation (2002)
-
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?
International Journal of Hematology (2002)